There's never a wrong time to consider the importance of marketing to women of color, and what it takes to do it properly. Learn more about how to connect and what you need to do to get it right.
Last year, Intouch had the pleasure of working with GSK/TESARO (now GSK) to create a powerful message for Ovarian Cancer Awareness Month, which is observed each September. To make #OvaryAct -- the socially driven, month-long campaign -- the most impactful it could be Intouch and GSK/TESARO worked with GIPHY to
Is your brand ready for Google's algorithm update that measures user experience? Read on to learn more.
The healthcare industry is still coping with the changes the pandemic has forced upon it -- and many of these changes likely won’t be reversed. Where does pharma fit now and in 2021? Get the Intouch/DHC Group whitepaper to find out.
DTC Perspectives recently hosted a webinar – Virtual DTC National: A COVID-19 Focused Event – that addressed how the COVID-19 pandemic has so far affected patients and other pharmaceutical and healthcare stakeholders. Get key takeaways from the event and register for Intouch's new whitepaper on the aftermath of COVID-19.
Join Wendy Blackburn, Intouch Group's EVP of marketing and communications, for a FREE virtual conference hosted by DTC Perspectives on all things COVID -- May 19, 2020.
Intouch is partnering with Heart to Heart International to help stop the spread of the coronavirus through a monetary donation and more.
How will COVID-19 affect pharma, and what can pharma marketers do to stay top of mind, while also providing the help searchers need in this uncertain time? Read on to find out.
COVID-19 is accelerating and amplifying healthcare trends, plus creating entirely new ones. In this Intouch POV, we provide strategic and tactical thought-starters for pharma marketers to effectively plan for 2021.
The COVID-19 pandemic has created new opportunities for pharmaceutical manufacturers to enhance their existing payer relationships while also delivering for HCPs and patients faced with navigating their new access and reimbursement realities.